Cardiac Rhythm Management Devices Market Trends

Cardiac Rhythm Management Devices Market Trends

The increasing prevalence of heart failure and other cardiovascular diseases are among the major factors propelling the cardiac rhythm management devices industry growth. Cardiovascular diseases (CVDs) are the leading cause of death globally. According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.
 

• The increasing incidence & prevalence of cardiovascular conditions, such as congestive heart failure, arrhythmias, bradycardia, and tachycardia is set to drive the business growth. As per Cardiac Failure Review, in 2023, heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64 million people globally. Heart failure continues to be linked to elevated mortality and morbidity rates, reduced quality life, and diminished functional capacity. This condition also places a significant burden on the healthcare system, both in terms of patient care and associated costs.
   
• The increasing incidence of cardiac abnormalities is expected to result in higher hospitalization rates and more medical procedures, which, in turn, is anticipated to boost the adoption of cardiac rhythm management devices. Various factors, such as poor dietary habits, decreased physical activity, rising tobacco usage, and excessive alcohol consumption, among others, have contributed to the increased occurrence and fatality rates associated with cardiovascular diseases.